Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
184
NCT05799339
Optimizing CAB-LA as PrEP for Women Who Inject Drugs
Phase: N/A
Role: Lead Sponsor
Start: Jan 13, 2022
Completion: Dec 31, 2025
NCT07025044
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
Start: Sep 3, 2025
Completion: Jun 1, 2026